Wolverine Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.64M | Buy |
94,100
+47,500
| +102% | +$1.26M | 0.03% | 489 |
|
|
2025
Q4 | $1.16M | Sell |
46,600
-37,500
| -45% | -$946K | 0.01% | 753 |
|
|
2025
Q3 | $2.14M | Sell |
84,100
-162,500
| -66% | -$4.01M | 0.02% | 535 |
|
|
2025
Q2 | $5.98M | Buy |
246,600
+54,200
| +28% | +$1.26M | 0.06% | 300 |
|
|
2025
Q1 | $4.88M | Buy |
192,400
+123,100
| +178% | +$3.22M | 0.06% | 307 |
|
|
2024
Q4 | $1.84M | Sell |
69,300
-37,000
| -35% | -$1M | 0.02% | 549 |
|
|
2024
Q3 | $3.08M | Buy |
106,300
+35,000
| +49% | +$1.02M | 0.03% | 399 |
|
|
2024
Q2 | $1.99M | Sell |
71,300
-14,200
| -17% | -$391K | 0.02% | 508 |
|
|
2024
Q1 | $2.37M | Sell |
85,500
-193,300
| -69% | -$5.36M | 0.03% | 451 |
|
|
2023
Q4 | $8.03M | Buy |
278,800
+145,200
| +109% | +$4.39M | 0.07% | 273 |
|
|
2023
Q3 | $4.43M | Buy |
133,600
+22,800
| +21% | +$806K | 0.05% | 343 |
|
|
2023
Q2 | $4.06M | Sell |
110,800
-72,800
| -40% | -$2.83M | 0.05% | 344 |
|
|
2023
Q1 | $7.49M | Buy |
183,600
+39,900
| +28% | +$1.72M | 0.09% | 253 |
|
|
2022
Q4 | $7.36M | Buy |
143,700
+124,500
| +648% | +$5.97M | 0.08% | 269 |
|
|
2022
Q3 | $840K | Buy |
+19,200
| New | +$933K | 0.01% | 846 |
|
|
2019
Q2 | – | Sell |
-21,712
| Closed | -$874K | – | 1564 |
|
|
2019
Q1 | $874K | Hold |
21,712
| – | – | 0.01% | 701 |
|
|
2018
Q4 | $899K | Buy |
+21,712
| New | +$901K | 0.01% | 856 |
|
|
2018
Q2 | – | Sell |
-18,972
| Closed | -$638K | – | 1556 |
|
|
2018
Q1 | $638K | Sell |
18,972
-109,616
| -85% | -$3.77M | 0.01% | 919 |
|
|
2017
Q4 | $4.42M | Hold |
128,588
| – | – | 0.04% | 305 |
|
|
2017
Q3 | $4.36M | Buy |
128,588
+75,888
| +144% | +$2.44M | 0.05% | 284 |
|
|
2017
Q2 | $1.68M | Hold |
52,700
| – | – | 0.02% | 485 |
|
|
2017
Q1 | $1.71M | Sell |
52,700
-1,581
| -3% | -$49.8K | 0.03% | 425 |
|
|
2016
Q4 | $1.67M | Buy |
54,281
+52,700
| +3,333% | +$1.61M | 0.02% | 442 |
|
|
2016
Q3 | $50K | Hold |
1,581
| – | – | ﹤0.01% | 1050 |
|
|
2016
Q2 | $52K | Buy |
1,581
+1,565
| +9,781% | +$49.9K | ﹤0.01% | 1039 |
|
|
2016
Q1 | $3K | Sell |
16
-765
| -98% | -$21.9K | ﹤0.01% | 1147 |
|
|
2015
Q4 | $15K | Sell |
781
-450
| -37% | -$14.2K | ﹤0.01% | 1362 |
|
|
2015
Q3 | $205K | Hold |
1,231
| – | – | ﹤0.01% | 907 |
|
|
2015
Q2 | $126K | Buy |
1,231
+527
| +75% | +$17.2K | ﹤0.01% | 1051 |
|
|
2015
Q1 | $29K | Sell |
704
-1,645
| -70% | -$52.3K | ﹤0.01% | 1370 |
|
|
2014
Q4 | $102K | Sell |
2,349
-7
| -0.3% | -$201 | ﹤0.01% | 1187 |
|
|
2014
Q3 | $262K | Buy |
2,356
+462
| +24% | +$13K | 0.01% | 941 |
|
|
2014
Q2 | $255K | Buy |
1,894
+853
| +82% | +$24.3K | 0.01% | 833 |
|
|
2014
Q1 | $129K | Sell |
1,041
-11
| -1% | -$328 | ﹤0.01% | 1034 |
|
|
2013
Q4 | $189K | Buy |
1,052
+249
| +31% | +$7.25K | ﹤0.01% | 1186 |
|
|
2013
Q3 | $176K | Sell |
803
-3,173
| -80% | -$86.3K | ﹤0.01% | 1226 |
|
|
2013
Q2 | $2.31M | Buy |
+3,976
| New | +$110K | 0.06% | 270 |
|
Other funds holding PFE
VCM
VPM
Wolverine Asset Management's PFE Position: Q3 2025 in Review
Wolverine Asset Management sold out of Pfizer (PFE) in Q3 2025, closing a stake of 77,136 shares — an estimated $1.9M sold.
Wolverine Asset Management first reported a position in PFE in Q2 2013 and held it in 36 quarters. The position peaked at $24.1M in Q4 2015. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.
- Wolverine Asset Management reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
- Wolverine Asset Management sold 77,136 Pfizer shares in Q3 2025, an estimated $1.9M.
- Wolverine Asset Management first reported a position in Pfizer in Q2 2013 and held it in 36 quarters.
- Wolverine Asset Management's Pfizer position peaked at $24.1M in Q4 2015.
- 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.
Based on Wolverine Asset Management's 13F filing for Q3 2025, filed 28 Oct 2025.